IntelliPharmaCeutics’ Co-founders Selected for Science and Technology Award

TORONTO, Oct. 5, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, announced today that Dr. Isa Odidi, Chief Executive Officer and co-Chief Scientific Officer and Dr. Amina Odidi, President and co-Chief Scientific Officer of Intellipharmaceutics, have been selected to receive the Planet Africa Science and Technology Award. The 2010 edition of the prestigious Planet Africa Awards program is set to showcase leadership and excellence at the Roy Thomson Hall on Saturday, October 23rd in Toronto, Canada. The purpose of the awards program is to identify and recognize deserving individuals, organizations, businesses and agencies that make a profound difference in society and in the lives of people. Since 2004, the program has honoured and celebrated national and global achievers. Additional information regarding the awards ceremony can be found at www.planetafricagroup.com